ICYMI: Biogen says its Chief Executive Michel Vounatsos will step down and the drugmaker will pull back on selling its Alzheimer's treatment Aduhelm after struggles with its launch https://t.co/SUaPi3e4Yw pic.twitter.com/fY76QXi2Ei— Reuters (@Reuters) May 8, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


